Mini-Reviews in Medicinal Chemistry
Title:Meet Our Associate Editorial Board Member
Volume: 21 Issue: 10
Author(s): A. Maity
Affiliation:
Export Options
About this article
Cite this article as:
Maity A. , Meet Our Associate Editorial Board Member, Mini-Reviews in Medicinal Chemistry 2021; 21 (10) . https://dx.doi.org/10.2174/138955752110210319142646
DOI https://dx.doi.org/10.2174/138955752110210319142646 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
5
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Future Preventive and Therapeutic Targets for Transfusion-Related Acute Lung Injury
Current Pharmaceutical Design Cellular Signaling Crosstalk Between Multiple Receptors for Investigation of Pathophysiology in Multifactorial Diseases - What is Clinically-Relevant Crosstalk?
Current Medicinal Chemistry The Level of Cytokines in the Vitreous Body of Severe Proliferative Diabetic Retinopathy Patients Undergoing Posterior Vitrectomy
Current Pharmaceutical Design Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies
Current Pharmaceutical Design Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Current Pharmaceutical Design Meet Our Editorial Board Member:
Recent Patents on Anti-Infective Drug Discovery G4 Aptamers: Trends in Structural Design
Mini-Reviews in Medicinal Chemistry Design, Synthesis and In Vitro Release Studies of Co-Drugs for Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Sp/KLF Family and Tumor Angiogenesis in Pancreatic Cancer
Current Pharmaceutical Design Idiotype Vaccines for Human B-Cell Malignancies
Current Pharmaceutical Design Mammalian Cell Display and Somatic Hypermutation In Vitro for Human Antibody Discovery
Current Drug Discovery Technologies Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s
Current Medicinal Chemistry Prospects of Embryonic Stem Cells in Treatment of Hematopoietic Disorders
Current Pharmaceutical Biotechnology Neuroprotection for Amyotrophic Lateral Sclerosis: Role of Stem Cells, Growth Factors, and Gene Therapy
Central Nervous System Agents in Medicinal Chemistry Fractions of <i>Boswellia Serrata</i> Suppress LTA<sub>4</sub>, LTC<sub>4</sub>, Cyclooxygenase-2 Activities and mRNA in HL-60 Cells and Reduce Lung Inflammation in BALB/c Mice
Current Drug Discovery Technologies The Potential of Allergen Biochips
Recent Patents on Inflammation & Allergy Drug Discovery Gender, Hormones and the Transmissible Encephalopathies
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Cardiovascular Effects of Green Tea Catechins: Progress and Promise
Recent Patents on Cardiovascular Drug Discovery Patent Selections
Recent Patents on Food, Nutrition & Agriculture